Comments

Globus Medical Analyst Ratings

GMEDNYSE

Logo brought to you by Benzinga Data

Trade with Public

$86.50

-0.20-0.23%

At close: Dec 15, 4:00 PM EST

$87.99

1.491.72%

After Hours: 5:58 PM EST

Overview News Earnings Options Guidance

Analyst Ratings

Insider Trades Short Interest Government Trades Stock Report

Consensus Rating¹

Buy

Highest Price Target¹

$115.00

Lowest Price Target¹

$64.00

Consensus Price Target¹

$88.86

Globus Medical Analyst Ratings and Price Targets | NYSE:GMED | Benzinga

Globus Medical Inc has a consensus price target of $88.86 based on the ratings of 18 analysts. The high is $115 issued by Roth MKM on December 17, 2024. The low is $64 issued by Stifel on October 28, 2025. The 3 most-recent analyst ratings were released by Morgan Stanley, Truist Securities, and Barclays on December 2, 2025, November 18, 2025, and November 10, 2025, respectively. With an average price target of $106.33 between Morgan Stanley, Truist Securities, and Barclays, there's an implied 20.85% upside for Globus Medical Inc from these most-recent analyst ratings.

Analyst Trends and Forecast

Jul

Aug

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Analyst Firms Making Recommendations¹

Morgan Stanley

Truist Securities

Barclays

RBC Capital

Wells Fargo

¹calculated from analyst ratings

Analyst Ratings for Globus Medical

					Get Alert
Dec 2, 2025	13.65%	Drew RanieriMorgan Stanley 46%	70 100	Previous Overweight Current Overweight	Get Alert
Nov 18, 2025	19.33%	Richard NewitterTruist Securities 70%	93 105	Previous Buy Current Buy	Get Alert
Nov 10, 2025	29.56%	Matt MiksicBarclays 67%	106 114	Previous Overweight Current Overweight	Get Alert
Nov 7, 2025	4.56%	Shagun SinghRBC Capital 59%	88 92	Previous Outperform Current Outperform	Get Alert
Nov 7, 2025	-10.22%	Vik ChopraWells Fargo 55%	66 79	Previous Overweight Current Overweight	Get Alert
Nov 7, 2025	3.42%	Craig BijouB of A Securities 74%	65 91	Previous Neutral Current Buy	Get Alert
Nov 7, 2025	5.69%	Richard NewitterTruist Securities 70%	65 93	Previous Hold Current Buy	Get Alert
Oct 28, 2025	-27.26%	Thomas StephanStifel 52%	64	Previous Current Hold	Get Alert
Aug 8, 2025	-24.99%	Vik ChopraWells Fargo 55%	66 76	Previous Overweight Current Overweight	Get Alert
Jul 22, 2025	2.28%	William PlovanicCanaccord Genuity 61%	90 97	Previous Buy Current Buy	Get Alert
Jul 21, 2025	—	David SaxonNeedham 60%	—	Previous Hold Current Hold	Get Alert
Jul 15, 2025	-22.72%	Drew RanieriMorgan Stanley 46%	68 75	Previous Overweight Current Overweight	Get Alert
May 27, 2025	—	David TurkalyJMP Securities 51%	—	Previous Market Perform Current Market Perform	Get Alert
May 27, 2025	—	Ryan ZimmermanBTIG 69%	—	Previous Buy Current Neutral	Get Alert
May 12, 2025	-22.72%	Richard NewitterTruist Securities 70%	68 80	Previous Hold Current Hold	Get Alert
May 9, 2025	-12.49%	Ryan ZimmermanBTIG 69%	77 88	Previous Buy Current Buy	Get Alert
May 9, 2025	-9.08%	Matt O'BrienPiper Sandler 53%	80 100	Previous Overweight Current Overweight	Get Alert
Apr 11, 2025	-9.08%	Richard NewitterTruist Securities 70%	80 82	Previous Hold Current Hold	Get Alert
Apr 9, 2025	0.01%	Ryan ZimmermanBTIG 69%	88 94	Previous Buy Current Buy	Get Alert
Mar 18, 2025	-6.81%	Richard NewitterTruist Securities 70%	82 90	Previous Hold Current Hold	Get Alert
Mar 18, 2025	—	David SaxonNeedham 60%	—	Previous Hold Current Hold	Get Alert
Feb 24, 2025	—	David TurkalyCitizens Capital Markets 51%	—	Previous Market Perform Current Market Perform	Get Alert
Feb 24, 2025	17.06%	Matt MiksicBarclays 67%	100 103	Previous Overweight Current Overweight	Get Alert
Feb 21, 2025	6.83%	Ryan ZimmermanBTIG 69%	91 94	Previous Buy Current Buy	Get Alert
Feb 21, 2025	6.83%	Mathew BlackmanStifel 66%	92 94	Previous Buy Current Buy	Get Alert
Feb 21, 2025	5.69%	Vik ChopraWells Fargo 55%	93 95	Previous Overweight Current Overweight	Get Alert
Feb 21, 2025	—	David SaxonNeedham 60%	—	Previous Hold Current Hold	Get Alert
Feb 6, 2025	—	David SaxonNeedham 60%	—	Previous Hold Current Hold	Get Alert
Jan 10, 2025	14.79%	William PlovanicCanaccord Genuity 61%	92 101	Previous Buy Current Buy	Get Alert
Jan 9, 2025	10.24%	Craig BijouB of A Securities 74%	80 97	Previous Underperform Current Neutral	Get Alert
Jan 9, 2025	—	David SaxonNeedham 60%	—	Previous Hold Current Hold	Get Alert
Dec 18, 2024	2.28%	Richard NewitterTruist Securities 70%	85 90	Previous Hold Current Hold	Get Alert
Dec 17, 2024	30.7%	Jason WittesRoth MKM 56%	100 115	Previous Buy Current Buy	Get Alert
Dec 12, 2024	3.42%	Ryan ZimmermanBTIG 69%	87 91	Previous Buy Current Buy	Get Alert
Dec 11, 2024	7.97%	Vik ChopraWells Fargo 55%	88 95	Previous Overweight Current Overweight	Get Alert
Dec 9, 2024	4.56%	William PlovanicCanaccord Genuity 61%	85 92	Previous Buy Current Buy	Get Alert
Dec 2, 2024	13.65%	Drew RanieriMorgan Stanley 46%	83 100	Previous Equal-Weight Current Overweight	Get Alert
Nov 11, 2024	-5.67%	Drew RanieriMorgan Stanley 46%	74 83	Previous Equal-Weight Current Equal-Weight	Get Alert
Nov 7, 2024	13.65%	Matt MiksicBarclays 67%	93 100	Previous Overweight Current Overweight	Get Alert
Nov 7, 2024	—	David SaxonNeedham 60%	—	Previous Current Hold	Get Alert
Nov 6, 2024	4.56%	Mathew BlackmanStifel 66%	80 92	Previous Buy Current Buy	Get Alert
Nov 6, 2024	-3.4%	William PlovanicCanaccord Genuity 61%	79 85	Previous Buy Current Buy	Get Alert
Nov 6, 2024	13.65%	Jason WittesRoth MKM 56%	100 100	Previous Buy Current Buy	Get Alert
Nov 6, 2024	4.56%	Shagun SinghRBC Capital 59%	80 92	Previous Outperform Current Outperform	Get Alert
Nov 6, 2024	0.01%	Vik ChopraWells Fargo 55%	78 88	Previous Overweight Current Overweight	Get Alert
Nov 6, 2024	13.65%	Matt O'BrienPiper Sandler 53%	80 100	Previous Overweight Current Overweight	Get Alert
Nov 6, 2024	-9.08%	Craig BijouB of A Securities 74%	55 80	Previous Underperform Current Underperform	Get Alert
Nov 6, 2024	—	David SaxonNeedham 60%	—	Previous Current Hold	Get Alert
Oct 14, 2024	-11.35%	Ryan ZimmermanBTIG 69%	77 78	Previous Buy Current Buy	Get Alert
Oct 8, 2024	-9.08%	Shagun SinghRBC Capital 59%	78 80	Previous Outperform Current Outperform	Get Alert
Aug 28, 2024	-12.49%	Ryan ZimmermanBTIG 69%	75 77	Previous Buy Current Buy	Get Alert
Aug 8, 2024	5.69%	Matt MiksicBarclays 67%	85 93	Previous Overweight Current Overweight	Get Alert
Aug 7, 2024	-11.35%	Shagun SinghRBC Capital 59%	76 78	Previous Outperform Current Outperform	Get Alert
Aug 7, 2024	-10.22%	Richard NewitterTruist Securities 70%	78 79	Previous Hold Current Hold	Get Alert
Aug 7, 2024	-11.35%	Vik ChopraWells Fargo 55%	60 78	Previous Equal-Weight Current Overweight	Get Alert
Aug 7, 2024	—	David SaxonNeedham 60%	—	Previous Current Hold	Get Alert
Jul 16, 2024	-11.35%	Richard NewitterTruist Securities 70%	63 78	Previous Hold Current Hold	Get Alert
Jul 15, 2024	-14.76%	Ryan ZimmermanBTIG 69%	72 75	Previous Buy Current Buy	Get Alert
Jul 15, 2024	-19.31%	Drew RanieriMorgan Stanley 46%	67 71	Previous Equal-Weight Current Equal-Weight	Get Alert
May 29, 2024	-18.17%	Ryan ZimmermanBTIG 69%	63 72	Previous Buy Current Buy	Get Alert
May 20, 2024	-9.08%	Matt O'BrienPiper Sandler 53%	60 80	Previous Neutral Current Overweight	Get Alert
May 9, 2024	-3.4%	Matt MiksicBarclays 67%	83 85	Previous Overweight Current Overweight	Get Alert
May 8, 2024	-28.4%	Ryan ZimmermanBTIG 69%	60 63	Previous Buy Current Buy	Get Alert
May 8, 2024	-31.81%	Matt O'BrienPiper Sandler 53%	55 60	Previous Neutral Current Neutral	Get Alert
May 8, 2024	-20.45%	Mathew BlackmanStifel 66%	64 70	Previous Buy Current Buy	Get Alert
May 8, 2024	—	David SaxonNeedham 60%	—	Previous Current Hold	Get Alert
Mar 18, 2024	-31.81%	Ryan ZimmermanBTIG 69%	60	Previous Neutral Current Buy	Get Alert
Feb 21, 2024	-10.22%	Caitlin CroninCanaccord Genuity 64%	79	Previous Buy Current Buy	Get Alert
Feb 21, 2024	-31.81%	Richard NewitterTruist Securities 70%	58 60	Previous Hold Current Hold	Get Alert
Jan 11, 2024	-20.45%	Shagun SinghRBC Capital 59%	70 70	Previous Outperform Current Outperform	Get Alert
Dec 22, 2023	-34.08%	Richard NewitterTruist Securities 70%	53 58	Previous Hold Current Hold	Get Alert
Dec 20, 2023	-19.31%	Kyle RoseCanaccord Genuity 66%	67 71	Previous Buy Current Buy	Get Alert
Nov 14, 2023	-39.77%	Drew RanieriMorgan Stanley 46%	53 60	Previous Equal-Weight Current Equal-Weight	Get Alert
Nov 8, 2023	-39.77%	Richard NewitterTruist Securities 70%	53 58	Previous Hold Current Hold	Get Alert
Oct 20, 2023	-14.76%	Jason WittesRoth MKM 56%	75	Previous Initiates Current Buy	Get Alert
Oct 12, 2023	-2.26%	Matt MiksicBarclays 67%	77 86	Previous Overweight Current Overweight	Get Alert
Sep 19, 2023	-30.67%	Mathew BlackmanStifel 66%	61	Previous Hold Current Buy	Get Alert
Sep 15, 2023	-34.08%	Vik ChopraWells Fargo 55%	58 63	Previous Equal-Weight Current Equal-Weight	Get Alert
Sep 5, 2023	-26.13%	Richard NewitterTruist Securities 70%	65	Previous Hold Current Hold	Get Alert
Aug 7, 2023	-26.13%	Richard NewitterTruist Securities 70%	65 68	Previous Hold Current Hold	Get Alert
Aug 7, 2023	-12.49%	Matt MiksicBarclays 67%	75 77	Previous Overweight Current Overweight	Get Alert
Aug 4, 2023	-28.4%	Vik ChopraWells Fargo 55%	61 63	Previous Equal-Weight Current Equal-Weight	Get Alert
Jul 19, 2023	-22.72%	Richard NewitterTruist Securities 70%	64 68	Previous Hold Current Hold	Get Alert
May 31, 2023	-31.81%	Drew RanieriMorgan Stanley 46%	60 64	Previous Equal-Weight Current Equal-Weight	Get Alert
May 24, 2023	—	David TurkalyJMP Securities 51%	—	Previous Current Market Perform	Get Alert
May 5, 2023	-27.26%	Richard NewitterTruist Securities 70%	64 66	Previous Current Hold	Get Alert
Mar 30, 2023	-23.85%	Kyle RoseCanaccord Genuity 66%	67	Previous Hold Current Buy	Get Alert
Mar 28, 2023	-23.85%	Kyle RoseCanaccord Genuity 66%	67	Previous Current Hold	Get Alert
Feb 22, 2023	-27.26%	Drew RanieriMorgan Stanley 46%	64 78	Previous Equal-Weight Current Equal-Weight	Get Alert
Feb 22, 2023	-23.85%	Kyle RoseCanaccord Genuity 66%	67 75	Previous Current Hold	Get Alert
Feb 22, 2023	-30.67%	Vik ChopraWells Fargo 55%	61 67	Previous Current Equal-Weight	Get Alert
Feb 13, 2023	-28.4%	Craig BijouB of A Securities 74%	63 83	Previous Buy Current Underperform	Get Alert
Feb 10, 2023	-23.85%	Vik ChopraWells Fargo 55%	67 82	Previous Overweight Current Equal-Weight	Get Alert
Feb 10, 2023	-20.45%	Richard NewitterTruist Securities 70%	70	Previous Buy Current Hold	Get Alert
Feb 10, 2023	-20.45%	Jason WittesLoop Capital 56%	70 90	Previous Buy Current Hold	Get Alert
Feb 10, 2023	—	David SaxonNeedham 60%	—	Previous Buy Current Hold	Get Alert
Feb 10, 2023	—	Ryan ZimmermanBTIG 69%	—	Previous Buy Current Neutral	Get Alert
Feb 9, 2023	—	Matt O'BrienPiper Sandler 53%	—	Previous Overweight Current Neutral	Get Alert
Jan 6, 2023	-11.35%	Drew RanieriMorgan Stanley 46%	68 78	Previous Current Equal-Weight	Get Alert
Dec 20, 2022	-3.4%	Richard NewitterTruist Securities 70%	74 85	Previous Current Buy	Get Alert

FAQ

What is the target price for Globus Medical (GMED) stock?

The latest price target for Globus Medical (NYSE:GMED) was reported by Morgan Stanley on December 2, 2025. The analyst firm set a price target for $100.00 expecting GMED to rise to within 12 months (a possible 13.65% upside). 33 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Globus Medical (GMED)?

The latest analyst rating for Globus Medical (NYSE:GMED) was provided by Morgan Stanley, and Globus Medical maintained their overweight rating.

When was the last upgrade for Globus Medical (GMED)?

The last upgrade for Globus Medical Inc happened on November 7, 2025 when B of A Securities raised their price target to $91. B of A Securities previously had a neutral for Globus Medical Inc.

When was the last downgrade for Globus Medical (GMED)?

The last downgrade for Globus Medical Inc happened on May 27, 2025 when BTIG changed their price target from N/A to N/A for Globus Medical Inc.

When is the next analyst rating going to be posted or updated for Globus Medical (GMED)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Globus Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Globus Medical was filed on December 2, 2025 so you should expect the next rating to be made available sometime around December 2, 2026.

Is the Analyst Rating Globus Medical (GMED) correct?

While ratings are subjective and will change, the latest Globus Medical (GMED) rating was a maintained with a price target of $70.00 to $100.00. The current price Globus Medical (GMED) is trading at is $87.99, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.